CORREVIO PHARMA CORP. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - CAD | -.--% |
|
-5.08% | +3.70% |
| 2020 | Mark Corrigan Departs as CEO from Correvio Pharma Corp | CI |
| 2020 | Justin Renz, CFO Departs from Correvio Pharma Corp | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 27.65M | - | - | - | - | - | |
| 70.02B | ||||||
| 9.05B | ||||||
| 4.43B | ||||||
| 4.16B | ||||||
| 3.83B | - | - |
